262 related articles for article (PubMed ID: 10092661)
21. Signaling of type II oncostatin M receptor.
Auguste P; Guillet C; Fourcin M; Olivier C; Veziers J; Pouplard-Barthelaix A; Gascan H
J Biol Chem; 1997 Jun; 272(25):15760-4. PubMed ID: 9188471
[TBL] [Abstract][Full Text] [Related]
22. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells.
Matsuda T; Nakamura T; Nakao K; Arai T; Katsuki M; Heike T; Yokota T
EMBO J; 1999 Aug; 18(15):4261-9. PubMed ID: 10428964
[TBL] [Abstract][Full Text] [Related]
23. Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway.
Dani C; Chambers I; Johnstone S; Robertson M; Ebrahimi B; Saito M; Taga T; Li M; Burdon T; Nichols J; Smith A
Dev Biol; 1998 Nov; 203(1):149-62. PubMed ID: 9806780
[TBL] [Abstract][Full Text] [Related]
24. Activation of cytokine signaling through leukemia inhibitory factor receptor (LIFR)/gp130 attenuates ischemic brain injury in rats.
Suzuki S; Yamashita T; Tanaka K; Hattori H; Sawamoto K; Okano H; Suzuki N
J Cereb Blood Flow Metab; 2005 Jun; 25(6):685-93. PubMed ID: 15716858
[TBL] [Abstract][Full Text] [Related]
25. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
[TBL] [Abstract][Full Text] [Related]
26. Differential response of neuronal cells to a fusion protein of ciliary neurotrophic factor/soluble CNTF-receptor and leukemia inhibitory factor.
März P; Ozbek S; Fischer M; Voltz N; Otten U; Rose-John S
Eur J Biochem; 2002 Jun; 269(12):3023-31. PubMed ID: 12071967
[TBL] [Abstract][Full Text] [Related]
27. LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells.
Dahéron L; Opitz SL; Zaehres H; Lensch MW; Andrews PW; Itskovitz-Eldor J; Daley GQ
Stem Cells; 2004; 22(5):770-8. PubMed ID: 15342941
[TBL] [Abstract][Full Text] [Related]
28. Chimeric cytokine receptor can transduce expansion signals in interleukin 6 receptor alpha (IL-6Ralpha)-, IL-11Ralpha-, and gp130-low to -negative primitive hematopoietic progenitors.
Takagi M; Nakamura T; Sawada T; Kaneko A; Nozaki-Ukai M; Nakahata T; Yokota T; Heike T
Mol Biol Cell; 1999 Nov; 10(11):3633-42. PubMed ID: 10564261
[TBL] [Abstract][Full Text] [Related]
29. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
[TBL] [Abstract][Full Text] [Related]
30. Separate functions for the two modules of the membrane-proximal cytokine binding domain of glycoprotein 190, the leukemia inhibitory factor low affinity receptor, in ligand binding and receptor activation.
Voisin MB; Bitard J; Daburon S; Moreau JF; Taupin JL
J Biol Chem; 2002 Apr; 277(16):13682-92. PubMed ID: 11834739
[TBL] [Abstract][Full Text] [Related]
31. A sweat gland-derived differentiation activity acts through known cytokine signaling pathways.
Habecker BA; Symes AJ; Stahl N; Francis NJ; Economides A; Fink JS; Yancopoulos GD; Landis SC
J Biol Chem; 1997 Nov; 272(48):30421-8. PubMed ID: 9374533
[TBL] [Abstract][Full Text] [Related]
32. Activation of JAK-STAT and MAP kinases by leukemia inhibitory factor through gp130 in cardiac myocytes.
Kunisada K; Hirota H; Fujio Y; Matsui H; Tani Y; Yamauchi-Takihara K; Kishimoto T
Circulation; 1996 Nov; 94(10):2626-32. PubMed ID: 8921810
[TBL] [Abstract][Full Text] [Related]
33. Leukemia inhibitory factor enhances mast cell growth in a mast cell/fibroblast co-culture system through stat3 signaling pathway of fibroblasts.
Hiragun T; Morita E; Mihara S; Tanaka T; Gyotoku E; Kameyoshi Y; Yamamoto S
FEBS Lett; 2000 Dec; 487(2):219-23. PubMed ID: 11150513
[TBL] [Abstract][Full Text] [Related]
34. Identification of a gp130 cytokine receptor critical site involved in oncostatin M response.
Olivier C; Auguste P; Chabbert M; Lelièvre E; Chevalier S; Gascan H
J Biol Chem; 2000 Feb; 275(8):5648-56. PubMed ID: 10681548
[TBL] [Abstract][Full Text] [Related]
35. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
[TBL] [Abstract][Full Text] [Related]
36. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes.
Kunisada K; Tone E; Fujio Y; Matsui H; Yamauchi-Takihara K; Kishimoto T
Circulation; 1998 Jul; 98(4):346-52. PubMed ID: 9711940
[TBL] [Abstract][Full Text] [Related]
37. Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells.
Kim H; Hawley TS; Hawley RG; Baumann H
Mol Cell Biol; 1998 Mar; 18(3):1525-33. PubMed ID: 9488469
[TBL] [Abstract][Full Text] [Related]
38. gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation.
Tone E; Kunisada K; Kumanogoh A; Negoro S; Funamoto M; Osugi T; Kishimoto T; Yamauchi-Takihara K
Cytokine; 2000 Oct; 12(10):1512-8. PubMed ID: 11023666
[TBL] [Abstract][Full Text] [Related]
39. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors.
Stahl N; Farruggella TJ; Boulton TG; Zhong Z; Darnell JE; Yancopoulos GD
Science; 1995 Mar; 267(5202):1349-53. PubMed ID: 7871433
[TBL] [Abstract][Full Text] [Related]
40. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
